Ovidrel (choriogonadotropin alfa) / EMD Serono  >>  Phase 3
Welcome,         Profile    Billing    Logout  

8 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ovidrel (choriogonadotropin alfa) / EMD Serono
NCT00230815: A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa Injection in Oligoanovulatory Infertile Women Undergoing Ovulation Induction

Completed
3b
62
US
Follitropin alfa injected by Pen device, Gonal-f®, Recombinant Human Choriogonadotropin (r-hCG), Ovidrel®, Choriogonadotropin alfa
EMD Serono
Infertility
11/05
11/05
NCT01152866: An Open Label, Canadian Phase IIIb Study With Ovidrel in Ovulation Induction (OI) and Assisted Reproductive Technique (ART)

Completed
3
3
Canada
Choriogonadotropin alpha (r-hCG), Ovidrel
EMD Serono
Ovulation Induction, Infertility
12/04
12/04
NCT00335569: Clinical Tolerance and Equivalence of hCG-IBSA vs Recombinant Human Chorionic Gonadotrophin in Women Undergoing In Vitro Fertilisation

Completed
3
144
Europe
hCG-IBSA
IBSA Institut Biochimique SA
Infertility
 
12/08
ATTAC-PCO, NCT01185704 / 2007-007932-25: Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)

Completed
3
136
Europe
Cetrorelix acetate, Cetrotide®, Recombinant Human Choriogonadotropin (r-hCG), Ovitrelle®, Recombinant human follicle stimulating hormone (r-hFSH)
Merck KGaA, Darmstadt, Germany, Merck Serono S.A.S, France
Polycystic Ovarian Syndrome
10/11
02/12
PERSIST, NCT01297465 / 2010-023534-23: PERgoveriS In Stratified Treatment for Assisted Reproductive Technique

Completed
3
202
Europe, RoW
Gonal-f®, Follitropin alfa, Pergoveris®, Recombinant human chorionic gonadotropin (r-hCG), Ovidrel®, Ovitrelle®
Merck KGaA, Darmstadt, Germany, Merck Serono S.A., Geneva, Merck A/S, Denmark, Merck OY, Finland, Merck Serono S.A.S, France, Merck Serono GmbH, Germany, Merck A.E., Greece, Merck B.V., Netherlands, Merck SP. Z.O.O., Poland, Merck Serono S.P.A., Italy, Merck Services U.K. Ltd, UK, LLC Merck, Russia, Merck spol. s r.o., Slovakia, Merck Pharma, K.S., Slovakia
Assisted Reproductive Techniques, Reproductive Technology, Assisted
10/12
10/12
DA-3803, NCT01718119: Clinical Trial Comparing the Efficacy and Safety of and Ovidrel

Completed
3
180
RoW
r-hCG
Dong-A Pharmaceutical Co., Ltd.
Hyperovulation Induction for Assisted Reproduction Treatment
02/13
 
FASHION, NCT02449889: A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation

Completed
3
176
RoW
highly purified human chorionic gonadotropin, CHORAPUR, BREVACTID, recombinant human chorionic gonadotropin, OVIDREL, OVITRELLE
Ferring Pharmaceuticals
Infertility
07/17
03/18
NCT03440359: Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole

Completed
2/3
52
US
Progesterone Vaginal Gel 8%, Crinone 8% vaginal gel, Letrozole Oral Tablet, pelvic ultrasound, Ovidrel 250 MCG Per 0.5 ML Prefilled Syringe, recombinant hCG 250 mcg, Intrauterine insemination or timed intercourse
Eastern Virginia Medical School, Watson Pharmaceuticals
Polycystic Ovary Syndrome
11/16
12/17

Download Options